Position
Chief Legal Officer
Company
Sudo Biosciences
CarmelBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnology ResearchDescription
Sudo Biosciences has announced the appointment of Paul S. Bavier, J.D., as Chief Legal Officer. He brings over two decades of legal experience in the biotechnology industry and will contribute to the company's strategic and operational growth.
Quick answer
Sudo Biosciences Appoints Paul Bavier as Chief Legal Officer (December 4, 2025). Sudo Biosciences is based in Carmel, Indiana, United States.
- Who is the new Chief Legal Officer at Sudo Biosciences?
- Sudo Biosciences named Paul Bavier Chief Legal Officer, announced December 4, 2025.
- What did Sudo Biosciences announce on December 4, 2025?
- Sudo Biosciences has announced the appointment of Paul S. Bavier, J.D., as Chief Legal Officer. He brings over two decades of legal experience in the biotechnology industry and will contribute to the company's strategic and operational growth.
- What does Sudo Biosciences do?
- Sudo Biosciences is a clinical-stage biopharmaceutical company developing next-generation TYK2 inhibitors to transform the treatment of immune-mediated diseases.
- Where is Sudo Biosciences based?
- Sudo Biosciences is based in Carmel, Indiana, United States.
- Which similar companies made leadership changes around the same time?
- Ichnos Glenmark Innovation (December 4, 2025), Jubilant Therapeutics (December 2, 2025), VistaGen (December 1, 2025) and Expression Therapeutics (December 10, 2025) also announced leadership changes within 45 days of Sudo Biosciences.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Ichnos Glenmark Innovation Appoints Lida Pacaud as Interim Chief Executive Officer (December 4, 2025)
- Jubilant Pharmova Appoints Daniel J. O’Connor as Chief Executive Officer (December 2, 2025)
- Vistagen Appoints Nick Tressler as Chief Financial Officer (December 1, 2025)
- Expression Therapeutics Appoints David F. Townson as Chief Executive Officer (December 10, 2025)
- Centessa Pharmaceuticals Appoints Mario Alberto Accardi as CEO (December 12, 2025)
- Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel (December 18, 2025)
Who to call at Sudo Biosciences, and when
A new leader at Sudo Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Sudo Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sudo Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sudo Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sudo Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sudo Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.